Clinical Trial Update: FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis [Phase 3]

View source ↗

Summary

A Phase 3 trial for on-demand treatment and surgical prophylaxis in congenital fibrinogen deficiencies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Afibrinogenemia
• Hypofibrinogenemia

Drugs mentioned

• FIB Grifols (fibrinogen (human plasma-derived))

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Congenital Afibrinogenemia, Hypofibrinogenemia | Phase 3 | Status: WITHDRAWN